| Trial ID: | L0591 |
| Source ID: | NCT03427801
|
| Associated Drug: |
Erythropoiesis-Stimulating Agent
|
| Title: |
Effect of Erythropoiesis-Stimulating Agent Therapy in Patients Receiving Palliative Care of Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia of Chronic Kidney Disease
|
| Interventions: |
DRUG: Erythropoiesis-Stimulating Agent
|
| Outcome Measures: |
Primary: number of red cell transfusion, one year|days of hospitalisation, one year |
|
| Sponsor/Collaborators: |
Sponsor: Chinese University of Hong Kong
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
78
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2017-03-01
|
| Completion Date: |
2018-12-30
|
| Results First Posted: |
|
| Last Update Posted: |
2019-01-31
|
| Locations: |
Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories, SAR, Hong Kong
|
| URL: |
https://clinicaltrials.gov/show/NCT03427801
|
